Table 4.
Comparison of group 1 patients according to therapy for pulmonary embolism.
| Thrombolysis | Anticoagulation | p value∗ | |
|---|---|---|---|
| (n = 29) | (n = 12) | ||
| Age (years) | 70.0 (56.5–77.0) | 73.5 (68.5–88.0) | 0.094 |
| Male gender | 14 (48.3) | 4 (33.3) | 0.497 |
| Cancer history | 3 (10.3) | 4 (33.3) | 0.165 |
| Cardiopulmonary resuscitation | 11 (37.9) | 5 (41.7) | 1.000 |
| APACHE II score | 29.0 (17.0–20.5) | 18.0 (15.0–23.0) | 0.453 |
| Central emboli on CTPA | 24 (82.8) | 11 (91.7) | 0.423 |
| PA pressure (mmHg) | 50.0 (48.0–60.0) | 47.5 (35.0–60.0) | 0.287 |
| Vital signs | |||
| Heart rate (beats/min) | 108.0 (98.5–120.0) | 115.5 (107.0–120.0) | 0.216 |
| Systolic blood pressure | 88.0 (83.5–97.0) | 96.0 (88.5–102.0) | 0.250 |
| Diastolic blood pressure | 58.0 (56.0–64.0) | 56.0 (50.0–61.5) | 0.328 |
| Shock index >1∗ | 22 (75.9) | 10 (83.3) | 0.702 |
| Cardiopulmonary resuscitation | 16 (39.0) | 0 (0.0) | 0.003 |
| Arterial blood gas analysis | |||
| pH | 7.43 (7.34–7.47) | 7.43 (7.40–7.51) | 0.158 |
| PaCO2 (mmHg) | 31.1 (27.3–36.6) | 30.9 (26.5–33.7) | 0.488 |
| PaO2 (mmHg) | 59.0 (47.3–78.1) | 72.0 (57.1–92.7) | 0.205 |
| O2 saturation (%) | 90.1 (79.8–95.6) | 94.0 (91.4–97.3) | 0.068 |
| Troponin-T (ng/mL) | 0.13 (0.03–0.71) | 0.19 (0.08–1.00) | 0.342 |
| Invasive mechanical ventilation | 11 (37.9) | 4 (33.3) | 0.536 |
| Need for vasopressor therapy | 19 (65.5) | 9 (75.0) | 0.719 |
| Length of ICU stay (days) | 4.0 (2.0–7.0) | 3.5 (2.3–14.5) | 0.944 |
| Length of hospital stay (days) | 12.0 (6.5–20.5) | 14.0 (5.0–23.5) | 0.832 |
| ICU Mortality | 8 (27.6) | 5 (41.7) | 0.469 |
All values are expressed as numbers (percentages) or median (Interquartile range).
APACHE: acute physiology and chronic health evaluation; CTPA: computer tomography pulmonary angiography; ICU: intensive care unit; PA: pulmonary artery; PaCO2: partial pressure for carbon dioxide; PaO2: partial pressure for oxygen.
∗Shock index: heart rate/systolic blood pressure.